Hyunsuk Shim
Corporate Officer/Principal bei Emory University
Profil
Hyunsuk Shim is the founder of Altiris Therapeutics, Inc. founded in 2005 where she held the title of Member-Scientific Advisors in 2012.
She is currently an Assistant Professor at Emory University since 2002.
Dr. Shim was a Principal Investigator at Metastatix, Inc. from 2005 to 2009.
Dr. Shim earned a doctorate degree from the University of Illinois.
Aktive Positionen von Hyunsuk Shim
| Unternehmen | Position | Beginn |
|---|---|---|
| Emory University | Corporate Officer/Principal | 01.01.2002 |
Ehemalige bekannte Positionen von Hyunsuk Shim
| Unternehmen | Position | Ende |
|---|---|---|
Metastatix, Inc.
 Metastatix, Inc. Pharmaceuticals: MajorHealth Technology Metastatix, Inc. develops small molecule drugs to treat life-threatening diseases including cancer, HIV infection, and macular degeneration. It has developed a series of novel oral small-molecule CXCR4 inhibitors that have unprecedented biological activity in preclinical models. The company was founded in 2005 and is located in Tucker, GA. | Corporate Officer/Principal | 22.06.2009 |
Altiris Therapeutics, Inc.
 Altiris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Altiris Therapeutics, Inc. develops and commercializes small-molecule drug therapies. The company was founded by Dennis Liotta, Hyunsuk Shim and James P. Snyder in 2005 and is headquartered in Atlanta, GA. | Gründer | - |
Ausbildung von Hyunsuk Shim
| University of Illinois | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Metastatix, Inc.
Metastatix, Inc. Pharmaceuticals: MajorHealth Technology Metastatix, Inc. develops small molecule drugs to treat life-threatening diseases including cancer, HIV infection, and macular degeneration. It has developed a series of novel oral small-molecule CXCR4 inhibitors that have unprecedented biological activity in preclinical models. The company was founded in 2005 and is located in Tucker, GA. | Health Technology |
Altiris Therapeutics, Inc.
Altiris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Altiris Therapeutics, Inc. develops and commercializes small-molecule drug therapies. The company was founded by Dennis Liotta, Hyunsuk Shim and James P. Snyder in 2005 and is headquartered in Atlanta, GA. | Health Technology |
